Fischer Medical Ventures Ltd (formerly known as Fischer Chemic Limited), through its wholly owned subsidiary Time Medical International Ventures (India) Private Limited formalises its investment in Health Digital Technologies (HDT), joining their existing investors Samsung Ventures and sovereign wealth fund of Malaysia, Khazanah (through MTDC), to bring their tele-consultation platform and e-prescription pharmacy, i.e. DoctorOnCall beyond Malaysia market.

Fischer Medical Ventures Ltd (Fischer MV) is known for its affordable, and accessible medical diagnostic and imaging technologies, by leveraging cutting-edge innovations and AI-powered software  solutions  in  healthcare.   As  the  first  company  to  indigenously  manufacture  high- quality Magnetic Resonance Imaging (MRI) systems in India and owning a diverse portfolio of  breakthrough  diagnostic  solutions,  Fischer  MV  envision  to  grow  its  telehealth  offerings globally with HDT.

HDT  is  leading  Malaysia's  digital  healthcare  evolution  through  DoctorOnCall,  the nation's pioneering integrated platform offering a comprehensive healthcare ecosystem, seamlessly  merging  teleconsultations,  online  pharmacy  services,  a  dynamic  health services marketplace, cutting-edge insurance solutions, and bespoke corporate medical concierge services, all in 1 platform.  At the core of their innovation lies the Digital Health Exchange (DHX) platform, a game-changing solution that aggregates healthcare services from multiple  providers,  ensuring  unparalleled  service  integration  across  the  sector.  Through technological  innovation, HDT  bridges  the gap between patients,  healthcare providers,  and insurers, setting new benchmarks in accessibility, efficiency, and quality care in the digital age.

With a robust infrastructure encompassing more than 500 GP clinics network, engaging over  1.9  million  registered  users,  and  supporting  more  than  20  million  annual  visits, DoctorOnCall platform has redefined healthcare accessibility and convenience, with an intuitive  interface  that  integrates  teleconsultations,  online  pharmacy  services,  health services bookings, and bespoke medical concierge services. From frictionless know-your- customer  (KYC)  processes  to  robust  verification  protocols,  every  interaction  prioritizes security and user convenience. Whether it is selecting prescription medications, consulting with physicians, or managing health packages, users benefit from a streamlined experience in just three clicks.   HDT’s B2B strategy involves providing HealthTech solutions to hospitals, life sciences companies, and a vast insurance and corporate network including Allianz, AIA, FWD, Generali, Etiqa, Great Eastern and Prudential. Their commitment to regulatory compliance, data privacy, and security, ensures a seamless user experience and lead to its achievement of “Forbes Asia 100 to watch”.

The digital health industry in Malaysia is experiencing rapid growth,  projected to grow at    a    CAGR    of    approximately    15-25%    over    the    next    five    years    (source: grandviewresearch.com/industry-analysis/asia-pacific-digital-health-market-report). Malaysia healthcare market is fuelled by increasing adoption of telehealth, online pharmacy, and doctor booking services, as well as government initiatives to digitize healthcare, leading HDT to win a contract with Malayia’s largest Telco CelcomDigi to roll out digital healthcare services to more than 14,000 independent GPs that will enlarge DoctorOnCall’s network for delivery of care@home initiative and another contract to roll out “Dengue Test” in the country through their vast GP network.   Leveraging the triumph of their DoctorOnCall platform, HDT is also poised for exponential growth beyond Malaysia, making inroads to lead in Southeast Asia with a  recent  contract  win  from  a  hospital  group  in  Saudi  Arabia  and  actively  expanding  in Singapore and Indonesia, benefiting from the rising medical tourism in Malaysia.

Commenting on the investment, Mr. Ravindran Govindan, Executive Chairman & MD of Fischer  MV  states:  "DoctorOnCall  is  EBITA-positive,  proving  the  platform  is  relevant  in today’s market. Their growth strategy that leverages cutting-edge technology and deep market insights is aligned with Fischer MV, particularly their promising Telemedicine marketplace, AI-driven ecosystem that connects patients, healthcare providers, and insurers seamlessly. Our collaboration aims to expand their B2C markets as well as to acquire more corporate clients and insurance providers globally by leveraging on Fischer MV’s strong sales network and deep expertise in digital health across ASEAN, India, and the Middle East.”

Mr. Maran Virumandi, CEO of Health Digital Technologies shares his excitement with the collaboration: “Fischer MV’s funding and marketing support propel us toward our goal to expand our cross-border scalability, and global footprint.  Fischer MV will bring in invaluable expertise  and  innovation  to  the  table  and  we  look  forward  to  leverage  this  partnership  to enhance DoctorOnCall’s HealthTech capabilities and expand our combined reach together to revolutionize the healthcare landscape, making quality healthcare more accessible to all."

This strategic partnership between Fischer MV and HDT exemplifies a joint commitment to innovation,   accessibility,   and   excellence  in   digital   healthcare   delivery,   setting   a   new benchmark  for  the  industry  globally,  with  a  commitment  to  innovation,  affordability,  and quality.

#FischerMedicalVentures #HealthDigitalTechnologies #DoctorOnCall #Telehealth #DigitalHealth #Investment #Collaboration #SamsungVentures #Khazanah #MTDC #TeleConsultation #Eprescription #OnlinePharmacy #HealthcareInnovation #DigitalHealthExchange #AIPowered #HealthcareTech #MedicalI #MRI #HealthTech #MalaysianBusiness #MalaysiaHealthcare #GlobalHealthcare #DigitalHealthcare #HealthcareAccessibility #HealthcareEfficiency #PatientCare #UserConvenience #SecureHealthcare #Telemedicine #HealthServices

Twitter